The United States Renal Data System released its 2020 Annual Data Report, featuring the latest data accumulated through 2018. This report, funded by the National Institute of Diabetes and Digestive Kidney Diseases, provides an overview of the impact of kidney disease on the US population. The annual report developed by the USRDS serves as an invaluable resource for ASN and the kidney community in determining policy priorities and advocacy efforts. In addition to familiar findings health outcomes and health care spending related to kidney disease and kidney failure, the 2020 Annual Data Report reviews the impact of COVID-19 on kidney patients.
The United States Renal Data System released its 2020 Annual Data Report, featuring the latest data accumulated through 2018. This report, funded by the National Institute of Diabetes and Digestive Kidney Diseases, provides an overview of the impact of kidney disease on the US population. The annual report developed by the USRDS serves as an invaluable resource for ASN and the kidney community in determining policy priorities and advocacy efforts. In addition to familiar findings health outcomes and health care spending related to kidney disease and kidney failure, the 2020 Annual Data Report reviews the impact of COVID-19 on kidney patients.
Some topline insights highlighted by USRDS in their release announcement include:
- A 14.9% prevalence of CKD among US adults
- A death rate more than twice as high in people with versus without CKD
- A 40% increase in hospitalizations with acute kidney injury from 2009 to 2018 and a persistently large disparity in acute kidney injury between Black and White patients
- All-time highs in kidney transplants and graft survival among deceased donor transplants
- 23.2% of Medicare fee-for-service spending in patients with CKD and ESRD and continued growth of Medicare Advantage enrollment of dialysis patients
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory